By Peter W. Kalivas, PhD, President of the American College of Neuropsychopharmacology. Dr. Kalivas is Professor and Chair, Department of Neurosciences at the Medical University of South Carolina.
The American College of Neuropsychopharmacology (ACNP), founded in 1961, is the nation’s premier professional society in brain, behavior, and neuropharmacology research. The field of neuropsychopharmacology involves evaluating the effects of natural and synthetic compounds upon the brain, mind, and human behavior, and the ACNP serves as a forum for advancing the latest discoveries about the brain towards cures for neuropsychiatric diseases.
The core purpose of the ACNP is to catalyze and advance scientific discovery about disorders of the brain and behavior in order to help prevent, treat and cure brain diseases. The ACNP members are nominated from the national leadership in the fields of Biological Psychiatry and Neuroscience, and the College and its Annual Meeting are kept small by design (just over 1,000 members) in order to facilitate scientific exchange and career mentoring at the Meeting. Importantly, the ACNP is a venue at which the best scientists from academia, government, and industry gather to share, discuss, and debate their research. The College also plays a key role in mentoring early career clinicians and scientists in the field of neuropsychopharmacology via education, travel grants and providing individual mentors. Continue reading →
We applaud portions of the omnibus bill that support the nation’s research, innovation and public health ecosystem, which works to assure our future health and economic well-being. The growth in funding for the Food and Drug Administration, fueled in part by the common-sense return of the 2013 user fees, as well as the increases for the Centers for Disease Control and Prevention, the Agency for Healthcare Research and Quality and the National Science Foundation are welcome news.
But funding for the National Institutes of Health has been kept well below the level of scientific opportunity. We must eliminate sequestration once and for all, and grow our investment in NIH in order to slow and halt the progression of diseases and disabilities ranging from Alzheimer’s to diabetes to traumatic brain injury. The appropriators have worked in good faith to move the nation forward. But as long as Congress avoids the primary issues fueling our national debt – tax and entitlement reform – it will be difficult to invest robustly in solutions to our problems.
The Albert and Mary Lasker Foundation has announced the winners of its 2013 Awards:
- Richard H. Scheller (Genentech) and Thomas C. Südhof (Stanford University School of Medicine) will receive the Albert Lasker Basic Medical Research Award for discoveries concerning rapid release of neurotransmitters, a process key to the way our brain cells communicate.
- Graeme M. Clark (emeritus at University of Melbourne, Australia), Ingeborg Hochmair (MED-El, Innsbruck, Australia) and Blake S. Wilson (Duke University) will receive the Lasker~DeBakey Clinical Medical Research Award for the development of the modern cochlear implant — a device that allows the profoundly deaf to hear.
- Bill Gates and Melinda Gates will receive the Lasker~Bloomberg Public Service Award for inspiring philanthropy addressing the most pressing global health concerns. Continue reading →